Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$219K Sell
4,556
-31
-0.7% -$1.58K 0.14% 132
2026
Q2
$240K Buy
4,587
+687
+18% +$36.3K 0.15% 112
2026
Q1
$215K Buy
+3,900
New +$211K 0.14% 103

Other funds holding GSK

Blue Capital's GSK Position: Q3 2026 in Review

Blue Capital reduced its GSK (GSK) stake by 0.68% in Q3 2026, selling an estimated $1.58K and leaving 4,556 shares worth $219K. The position accounts for 0.14% of the portfolio, ranked #132.

Blue Capital first reported a position in GSK in Q1 2026 and has held it in 3 quarters since. The position peaked at $240K in Q2 2026. 854 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Blue Capital held 4,556 shares of GSK worth $219K as of Q3 2026.
  • Blue Capital sold 31 GSK shares in Q3 2026, an estimated $1.58K.
  • GSK made up 0.14% of Blue Capital's portfolio in Q3 2026, its #132 holding.
  • Blue Capital first reported a position in GSK in Q1 2026 and has held it in 3 quarters since.
  • Blue Capital's GSK position peaked at $240K in Q2 2026.
  • 854 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Blue Capital's 13F filing for Q3 2026, filed 13 Oct 2026.